← Back to headlines
GLP-1 Drugs Drive IHE's Performance, IXJ Pursues Long-Term Strategy
IHE experienced a significant year, attributed to the impact of GLP-1 drugs, while IXJ is reportedly focusing on a longer-term strategic approach in the market.
27 May, 15:37 — 27 May, 15:37
Sources
Showing 1 of 1 sources
